What is the per-share price Eli Lilly will pay?

Eli Lilly will pay $6.75 per share in cash.

What are the reasons for the acquisition?

Eli Lilly aims to strengthen its mental health portfolio and leverage AtaiBeckley's innovative platform.

How did Eli Lilly's stock (LLY) react to the announcement?

Eli Lilly's shares saw modest movement, while AtaiBeckley shares surged sharply.

Eli Lilly to Acquire AtaiBeckley for $2.8 Billion

Q: Will the deal require regulatory approvals?

Yes, the deal is subject to regulatory approvals, including antitrust clearance.

Eli Lilly (LLY) has agreed to acquire AtaiBeckley for $2.8 billion in cash, with additional potential payments of up to $1 billion upon achieving milestones. The acquisition strengthens Lilly's presence in mental health treatments.

July 16, 2026

2 min read

Source: GuruFocus.com

Key Numbers

deal value

$2.8 billion

cash per share

$6.75

milestones

$1 billion

Eli Lilly (NYSE: LLY) announced an agreement to acquire AtaiBeckley, a company specializing in mental health treatments, for $2.8 billion in cash, with up to $1 billion in additional milestone payments.

Deal Details

Total Value: $2.8 billion cash + up to $1 billion in milestones.
Price per Share: $6.75 per share.
Payment Method: All cash.
Premium: Not disclosed.

Rationale

The acquisition aims to bolster Eli Lilly's pipeline in mental health and leverage AtaiBeckley's innovative platform for developing new treatments for psychiatric and neurological disorders.

Regulatory Challenges

The deal is subject to regulatory approvals, including antitrust clearance. No specific timeline for closing has been announced.

Impact on Stocks

AtaiBeckley shares surged on the news, while Eli Lilly (LLY) shares saw modest movement. The acquisition is expected to positively impact Lilly's long-term growth prospects.

Frequently Asked Questions

The deal is valued at $2.8 billion in cash, with up to $1 billion in additional milestone payments.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.